Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q2 2022 Results - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2022 Results Earnings Conference Call August 4, 2022 8:00 AM ET

Company Participants

Ian Karp - Senior Vice President , Investor Relations and Corporate Communications
John Leonard - President and Chief Executive Officer
David Lebwohl - Executive Vice President and Chief Medical Officer
Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer
Glenn Goddard - Executive Vice President and Chief Financial Officer

Conference Call Participants

Joon Lee - Truist Securities
Maury Raycroft - Jefferies
Dae Gon Ha - Stifel
Gena Wang - Barclays
Joseph Thome - Cowen and Company
Swapnil Malekar - Piper Sandler
Salveen Richter - Goldman Sachs
Luca Issi - RBC Capital Markets
Richard Law - Credit Suisse
Greg Harrison - Bank of America
Mani Foroohar - SVB Leerink
Jay Olson - Oppenheimer & Co.
Ry Forseth - Guggenheim Partners
Kostas Biliouris - BMO Capital Markets
Yanan Zhu - Wells Fargo

Operator

Good morning. And welcome to the Intellia Therapeutics' Second Quarter 2022 Financial Results Conference Call. My name is Andrew and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. As a reminder, all participants are currently in listen-only mode. [Operator Instructions].

I will now turn the conference over to Ian Karp, Senior Vice President of Investor Relations and Corporate Communications at Intellia.

Ian Karp

Thank you, operator. And good morning, everyone. Welcome to Intellia Therapeutics second quarter 2022 earnings call. Earlier this morning, Intellia issued a press release outlining the company's progress this quarter as well as topics for discussion on today's call. This release can be found on the Investors and Media section of Intellia's website at intelliatx.com. This call is being broadcast